Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder.
FGF-23 及慢性腎病-礦物質與骨骼疾病標記的族群與季節變異。
Clin Kidney J 2024-07-29
Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease.
慢性腎臟病患者靜脈注射鐵劑對纖維母細胞生長因子23和磷酸鹽影響之比較性探索性雙盲隨機研究的方法論和基線數據。
Kidney Blood Press Res 2024-04-12
The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?
FGF-23 開放系統在額外降磷治療、貧血和發炎之間的交叉路口:如何應對完整和C端測定?
Clin Kidney J 2023-10-30
Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts.
慢性腎臟病患者血紅蛋白分佈的區域變異:ISN慢性腎臟病國際網絡。
Kidney Int Rep 2023-10-20
Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease.
慢性腎臟疾病患者中,纖維母細胞生長因子23與腎衰竭及死亡獨立相關,而 copeptin 則無。
Clin Kidney J 2023-12-05
Association of Fibroblast Growth Factor 23 with Blood Pressure in Primary Proteinuric Glomerulopathies.
原發性蛋白尿性腎小球病中纖維母細胞生長因子 23 與血壓的關聯。
Am J Nephrol 2024-04-05
Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices.
腎臟病學實踐中慢性腎臟病-礦物質骨骼疾病(CKD-MBD)生物標記的實際應用。
Clin Kidney J 2024-01-16